Efficacy and safety of ziltivekimab in patients with chronic kidney disease susceptible to inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials

Efficacy and safety of ziltivekimab in patients with chronic kidney disease susceptible to inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials

Abstract Background Patients with chronic kidney disease (CKD) are at risk of developing conditions such as atherosclerosis and inflammation-induced anemia (AI) due to persistent inflammation. Ziltivekimab, an antibody targeting interleukin-6, is being studied for its potential to reduce inflammator...

Full description

Saved in:
Bibliographic Details
Main Authors: Amr Elrosasy (Author), Dalal Sabbagh (Author), Mohammad Assaf (Author), Husam Tarakhan (Author), Ahmad Afyouni (Author), Marwa O. Elgendy (Author), Lamiaa N. Abdelaty (Author), Refaat H. Omar (Author), Ahmed Hamdy Zabady (Author)
Format: Book
Published: SpringerOpen, 2024-11-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items